Clinical Trial: A non-randomized, open-label, 2-treatment, 2-period, fixedsequence, crossover pharmacokinetic interaction study to investigate the effect of fluvoxamine on rovadicitinib (SAR449764) in healthy adult participants (China)

China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A non-randomized, open-label, 2-treatment, 2-period, fixedsequence, crossover pharmacokinetic interaction study to investigate the effect of fluvoxamine on rovadicitinib (SAR449764) in healthy adult participants'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135515

Registration Time: 2026/10/30

Type: Interventional study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347802

Published by HT Digital Content Services with permission from Health Daily Digest....